Thyrocare Technologies Limited (NSE:THYROCARE) — Stock Price

Rs622.10 INR
▲ 3.12% today

Thyrocare Technologies Limited (NSE:THYROCARE) is currently trading at Rs622.10 INR, up 3.12% today. Over the past 52 weeks, shares have ranged between Rs349.55 and Rs1591.90. This page tracks Thyrocare Technologies Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see THYROCARE market cap overview.

Thyrocare Technologies Limited (THYROCARE) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Thyrocare Technologies Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Thyrocare Technologies Limited Income Statement — Revenue, Profit & Earnings by Year

Thyrocare Technologies Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs8.29 Billion Rs6.87 Billion Rs5.72 Billion Rs5.27 Billion Rs5.89 Billion
Cost of Revenue Rs4.16 Billion Rs1.91 Billion Rs3.91 Billion Rs1.63 Billion Rs1.70 Billion
Gross Profit Rs4.13 Billion Rs4.96 Billion Rs1.81 Billion Rs3.63 Billion Rs4.19 Billion
Research & Development — — — — —
SG&A — Rs371.20 Million Rs330.10 Million Rs233.50 Million Rs173.80 Million
Total Operating Expenses Rs2.09 Billion Rs3.61 Billion Rs849.70 Million Rs2.79 Billion Rs2.18 Billion
Operating Income Rs2.03 Billion Rs1.35 Billion Rs958.40 Million Rs865.50 Million Rs2.01 Billion
EBITDA Rs2.62 Billion Rs2.04 Billion Rs1.48 Billion Rs1.31 Billion Rs2.64 Billion
EBIT Rs2.03 Billion Rs1.48 Billion Rs1.01 Billion Rs922.40 Million Rs2.30 Billion
Interest Expense Rs28.00 Million Rs30.50 Million Rs55.30 Million Rs48.30 Million Rs23.70 Million
Income Before Tax Rs2.13 Billion Rs1.45 Billion Rs955.90 Million Rs885.90 Million Rs2.28 Billion
Income Tax Expense Rs500.30 Million Rs546.90 Million Rs264.90 Million Rs242.30 Million Rs515.80 Million
Net Income Rs1.63 Billion Rs915.10 Million Rs707.60 Million Rs644.90 Million Rs1.76 Billion

Thyrocare Technologies Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Thyrocare Technologies Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs7.47 Billion Rs6.93 Billion Rs6.44 Billion Rs6.33 Billion Rs6.08 Billion
Total Current Assets Rs3.72 Billion Rs3.38 Billion Rs2.79 Billion Rs2.73 Billion Rs2.70 Billion
Cash & Equivalents — Rs176.80 Million Rs93.00 Million Rs177.70 Million Rs136.30 Million
Short-term Investments Rs1.51 Billion Rs1.74 Billion Rs1.67 Billion Rs1.33 Billion Rs1.25 Billion
Net Receivables Rs738.80 Million Rs821.80 Million Rs441.60 Million Rs856.70 Million Rs944.80 Million
Inventory Rs484.60 Million Rs537.90 Million Rs475.20 Million Rs302.30 Million Rs344.30 Million
Property, Plant & Equipment — Rs1.98 Billion Rs2.04 Billion Rs1.94 Billion Rs1.87 Billion
Goodwill Rs1.08 Billion Rs1.08 Billion Rs1.04 Billion Rs1.00 Billion Rs1.00 Billion
Total Liabilities Rs1.61 Billion Rs1.46 Billion Rs1.16 Billion Rs975.00 Million Rs810.90 Million
Total Current Liabilities Rs1.10 Billion Rs1.22 Billion Rs904.80 Million Rs771.00 Million Rs645.20 Million
Long-term Debt — Rs0.00 Rs109.10 Million Rs0.00 —
Net Debt Rs-174.70 Million Rs70.00 Million Rs330.40 Million Rs55.40 Million Rs70.70 Million
Total Stockholder Equity Rs5.86 Billion Rs5.47 Billion Rs5.27 Billion Rs5.34 Billion Rs5.27 Billion
Retained Earnings — Rs3.15 Billion Rs3.19 Billion Rs3.43 Billion Rs3.57 Billion

Thyrocare Technologies Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Thyrocare Technologies Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs2.16 Billion Rs1.91 Billion Rs1.68 Billion Rs1.29 Billion Rs1.13 Billion
Capital Expenditures Rs208.80 Million Rs448.90 Million Rs615.80 Million Rs436.50 Million Rs378.30 Million
Free Cash Flow Rs1.95 Billion Rs1.46 Billion Rs1.06 Billion Rs856.60 Million Rs755.80 Million
Investing Cash Flow Rs-260.80 Million Rs-525.20 Million Rs-912.80 Million Rs-389.90 Million Rs-235.70 Million
Financing Cash Flow Rs-1.70 Billion Rs-1.30 Billion Rs-848.00 Million Rs-861.80 Million Rs-894.10 Million
Dividends Paid Rs1.48 Billion Rs953.10 Million Rs952.70 Million Rs793.60 Million Rs793.10 Million
Stock-Based Compensation Rs240.90 Million Rs245.10 Million Rs166.70 Million Rs211.70 Million Rs23.20 Million
Depreciation Rs585.80 Million Rs552.60 Million Rs470.10 Million Rs387.10 Million Rs338.70 Million
Change in Cash Rs503.10 Million Rs83.80 Million Rs-84.70 Million Rs41.40 Million Rs4.30 Million

Thyrocare Technologies Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Thyrocare Technologies Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 07, 2026 2.98 5.40 -44.81%
Jan 28, 2026 2.11 1.90 +11.05%
Oct 21, 2025 — — —
Jul 23, 2025 2.44 1.70 +43.53%
Apr 23, 2025 1.39 1.60 -13.13%
Jan 23, 2025 1.19 1.40 -15.00%
Oct 23, 2024 1.66 1.70 -2.35%
Jul 23, 2024 1.50 1.50 +0.00%